Cargando…

Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study

BACKGROUND: Traditional Chinese medicine (TCM) is used in the treatment of many conditions, including heart failure (HF), although it is not well characterized. METHODS AND RESULTS: We conducted a retrospective analysis of TCM use in a random sample of hospitalizations for HF within a random sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yuan, Spatz, Erica S., Tan, Qi, Liu, Shuling, Lu, Yuan, Masoudi, Frederick A., Schulz, Wade L., Krumholz, Harlan M., Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761625/
https://www.ncbi.nlm.nih.gov/pubmed/31364457
http://dx.doi.org/10.1161/JAHA.119.012776
_version_ 1783454060588826624
author Yu, Yuan
Spatz, Erica S.
Tan, Qi
Liu, Shuling
Lu, Yuan
Masoudi, Frederick A.
Schulz, Wade L.
Krumholz, Harlan M.
Li, Jing
author_facet Yu, Yuan
Spatz, Erica S.
Tan, Qi
Liu, Shuling
Lu, Yuan
Masoudi, Frederick A.
Schulz, Wade L.
Krumholz, Harlan M.
Li, Jing
author_sort Yu, Yuan
collection PubMed
description BACKGROUND: Traditional Chinese medicine (TCM) is used in the treatment of many conditions, including heart failure (HF), although it is not well characterized. METHODS AND RESULTS: We conducted a retrospective analysis of TCM use in a random sample of hospitalizations for HF within a random sample of Western medicine hospitals in China in 2015 using data from the China PEACE 5r‐HF (China Patient‐Centered Evaluative Assessment of Cardiac Events 5 Retrospective Heart Failure Study). We describe the frequency of TCM use and its association with patient characteristics, in‐hospital use of evidence‐based therapies, and hospital characteristics using hierarchical logistic regression models. Finally, we assessed risk‐adjusted in‐hospital bleeding and mortality. Among 10 004 patients hospitalized with HF (median age, 73 years; 48.9% women) from 189 hospitals, 74.7% received TCM (83.3% administered intravenously). The most commonly used agent was Salvia miltiorrhiza (51.2%). Patients with coronary artery disease (odds ratio [OR], 1.73; 95% CI, 1.53–1.95) or stroke (OR, 1.32; 95% CI, 1.15–1.51) were more likely to receive TCM; there was no correlation with evidence‐based therapy use. Nearly all hospitals (99.4%) used TCM, with substantial variation across hospitals (median OR, 3.29; 95% CI, 2.82–3.76). In‐patient bleeding (OR, 1.39; 95% CI, 1.03–1.88) and mortality (OR, 1.36; 95% CI, 1.04–1.79) were higher with Salvia miltiorrhiza, although not with other TCMs. CONCLUSIONS: In a nationally representative sample of patients hospitalized with acute HF in China, three fourths received TCM. Nearly all hospitals used TCM, although use varied substantially by hospital. Although TCM was not used in lieu of evidence‐based therapies for HF, we found a signal for harm with the most commonly used TCM. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02877914.
format Online
Article
Text
id pubmed-6761625
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67616252019-09-30 Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study Yu, Yuan Spatz, Erica S. Tan, Qi Liu, Shuling Lu, Yuan Masoudi, Frederick A. Schulz, Wade L. Krumholz, Harlan M. Li, Jing J Am Heart Assoc Original Research BACKGROUND: Traditional Chinese medicine (TCM) is used in the treatment of many conditions, including heart failure (HF), although it is not well characterized. METHODS AND RESULTS: We conducted a retrospective analysis of TCM use in a random sample of hospitalizations for HF within a random sample of Western medicine hospitals in China in 2015 using data from the China PEACE 5r‐HF (China Patient‐Centered Evaluative Assessment of Cardiac Events 5 Retrospective Heart Failure Study). We describe the frequency of TCM use and its association with patient characteristics, in‐hospital use of evidence‐based therapies, and hospital characteristics using hierarchical logistic regression models. Finally, we assessed risk‐adjusted in‐hospital bleeding and mortality. Among 10 004 patients hospitalized with HF (median age, 73 years; 48.9% women) from 189 hospitals, 74.7% received TCM (83.3% administered intravenously). The most commonly used agent was Salvia miltiorrhiza (51.2%). Patients with coronary artery disease (odds ratio [OR], 1.73; 95% CI, 1.53–1.95) or stroke (OR, 1.32; 95% CI, 1.15–1.51) were more likely to receive TCM; there was no correlation with evidence‐based therapy use. Nearly all hospitals (99.4%) used TCM, with substantial variation across hospitals (median OR, 3.29; 95% CI, 2.82–3.76). In‐patient bleeding (OR, 1.39; 95% CI, 1.03–1.88) and mortality (OR, 1.36; 95% CI, 1.04–1.79) were higher with Salvia miltiorrhiza, although not with other TCMs. CONCLUSIONS: In a nationally representative sample of patients hospitalized with acute HF in China, three fourths received TCM. Nearly all hospitals used TCM, although use varied substantially by hospital. Although TCM was not used in lieu of evidence‐based therapies for HF, we found a signal for harm with the most commonly used TCM. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02877914. John Wiley and Sons Inc. 2019-07-31 /pmc/articles/PMC6761625/ /pubmed/31364457 http://dx.doi.org/10.1161/JAHA.119.012776 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Yu, Yuan
Spatz, Erica S.
Tan, Qi
Liu, Shuling
Lu, Yuan
Masoudi, Frederick A.
Schulz, Wade L.
Krumholz, Harlan M.
Li, Jing
Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
title Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
title_full Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
title_fullStr Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
title_full_unstemmed Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
title_short Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
title_sort traditional chinese medicine use in the treatment of acute heart failure in western medicine hospitals in china: analysis from the china peace retrospective heart failure study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761625/
https://www.ncbi.nlm.nih.gov/pubmed/31364457
http://dx.doi.org/10.1161/JAHA.119.012776
work_keys_str_mv AT yuyuan traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy
AT spatzericas traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy
AT tanqi traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy
AT liushuling traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy
AT luyuan traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy
AT masoudifredericka traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy
AT schulzwadel traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy
AT krumholzharlanm traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy
AT lijing traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy
AT traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy